These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29538755)

  • 41. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
    Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
    Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
    Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.
    Durán J; Combe B; Niu J; Rincheval N; Gaujoux-Viala C; Felson DT
    Rheumatology (Oxford); 2015 Dec; 54(12):2166-70. PubMed ID: 26175470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria.
    Iking-Konert C; Aringer M; Wollenhaupt J; Mosch T; Tuerk S; Feist E; Burmester GR
    Ann Rheum Dis; 2011 Nov; 70(11):1986-90. PubMed ID: 21875873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.
    Wang GY; Zhang SL; Wang XR; Feng M; Li C; An Y; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Yan HM; Wang GC; Lu X; Liu X; Zhu P; Chen LN; Jin HT; Liu JT; Guo HF; Chen HY; Xie JL; Wei P; Wang JX; Liu XY; Sun L; Cui LF; Shu R; Liu BL; Yu P; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Han SL; Yang XY; Li H; Huang CB; Gao M; Lai B; Cheng YJ; Li XF; Song LJ; Yu XX; Wang AX; Wu LJ; Wang YH; He L; Sun WW; Gong L; Wang XY; Wang Y; Zhao Y; Li XX; Wang Y; Zhang Y; Su Y; Zhang CF; Mu R; Li ZG
    Clin Rheumatol; 2015 Feb; 34(2):221-30. PubMed ID: 25413735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
    Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
    Burmester GR; Ferraccioli G; Flipo RM; Monteagudo-Sáez I; Unnebrink K; Kary S; Kupper H
    Arthritis Rheum; 2008 Jan; 59(1):32-41. PubMed ID: 18163417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis].
    Avdeeva AS; Aleksandrova EN; Novikov AA; Cherkasova MV; Panasyuk EY; Nasonov EL
    Ter Arkh; 2013; 85(5):24-9. PubMed ID: 23819335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
    Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
    BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target.
    Legrand J; Kirchgesner T; Sokolova T; Vande Berg B; Durez P
    Joint Bone Spine; 2019 Oct; 86(5):594-599. PubMed ID: 30928534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
    Britsemmer K; van Schaardenburg D; Boers M; De Cock D; Verschueren P; Radner H; Smolen JS; van Tuyl LHD
    Clin Exp Rheumatol; 2018; 36(3):362-370. PubMed ID: 29533752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
    Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
    Ranganath VK; Maranian P; Elashoff DA; Woodworth T; Khanna D; Hahn T; Sarkisian C; Kremer JM; Furst DE; Paulus HE
    Rheumatology (Oxford); 2013 Oct; 52(10):1809-17. PubMed ID: 23813577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
    Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
    Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Treat-to-target Strategies Aiming at Remission of Arterial Stiffness in Early Rheumatoid Arthritis: A Randomized Controlled Study.
    Tam LH; Shang Q; Li EK; Wong PC; Kwok KY; Kun EW; Yim IC; Lee VK; Yip RM; Pang SH; Lao VW; Mak QW; Cheng IT; Lau XS; Li TK; Zhu TY; Lee AP; Tam LS
    J Rheumatol; 2018 Aug; 45(9):1229-1239. PubMed ID: 29764965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
    Haugeberg G; Hansen IJ; Soldal DM; Sokka T
    Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.